Your fact-checks will appear here
Testosterone is used off-label for the treatment of female hypoactive sexual desire, but its efficacy and safety have not been established in randomized controlled trials.
There are no published randomized, head‑to‑head clinical trials directly comparing , , and for ; the available evidence comes from separate placebo‑controlled trials, systematic reviews, and critiques...
A twice‑weekly regimen of 0.3 mL per injection of a 200 mg/mL testosterone preparation delivers 60 mg per shot (120 mg/week) and — based on published pharmacokinetics and clinical dosing data — would ...
Evidence converges on a clear theme: in women as a relational problem — improving sexual communication, addressing broader relationship needs, and using psychological therapies (CBT and ) delivered in...